Maternofetal transmission of human immunodeficiency virus-1: The role of antibodies to the V<inf>3</inf> primary neutralizing domain

Arye Rubinstein, Harris Goldstein, Theresa Calvelli, Yair Devash, Ran Rubinstein, Ruy Soeiro, William Lyman

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The increase in the number of human immunodeficiency virus-1 (HIV-1)-infected children is a direct consequence of the heterosexual spread of the disease to women and the growing number of HIV-positive i.v. drug users. It is not known how the majority of infants born to HIV-1-infected women escape HIV-1 infection, and, for those infected, the timing of HIV-1 transmission has yet to be determined. In addition, the role of maternal antibodies in the prevention of HIV-1 transmission to the fetus is unclear. We have previously demonstrated a correlation between vertical transmission and the absence of high-affinity/avidity antibodies to a peptide, KRI-HIGPGRAFYT, which corresponds to a region of the primary neutralizing domain of the gpl20 V<inf>3</inf> loop of HIV<inf>MN</inf> (MN-PND). The present study examines the correlation between the presence of these high affinity antibodies in women completing a pregnancy or undergoing an elective abortion and the detection of HIV-1 infection in their aborted fetuses. In several instances, transmission occurred despite high-affinity antibodies to the MN-PND. We have, therefore, evaluated the reactivity of sera to different MN-PND variants. In one infant born to a mother with high-affinity/avidity antibodies to KRI-HIGPGRAFYT (classic MN-PND), the infected baby developed antibodies to an MN-PND variant peptide against which his mother did not mount a humoral immune response during pregnancy. This finding indicates that fetal infection with MN-PND escape mutants arising during pregnancy may occur during a period when the mother is serologically negative.

Original languageEnglish (US)
Pages (from-to)S76-S79
JournalPediatric Research
Volume33
Issue number1
StatePublished - 1993

Fingerprint

Antibody Affinity
HIV-1
Antibodies
Mothers
Virus Diseases
Pregnancy
Aborted Fetus
Peptides
Heterosexuality
Humoral Immunity
Drug Users
Fetus
HIV
Infection
Serum

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Maternofetal transmission of human immunodeficiency virus-1 : The role of antibodies to the V<inf>3</inf> primary neutralizing domain. / Rubinstein, Arye; Goldstein, Harris; Calvelli, Theresa; Devash, Yair; Rubinstein, Ran; Soeiro, Ruy; Lyman, William.

In: Pediatric Research, Vol. 33, No. 1, 1993, p. S76-S79.

Research output: Contribution to journalArticle

Rubinstein, Arye ; Goldstein, Harris ; Calvelli, Theresa ; Devash, Yair ; Rubinstein, Ran ; Soeiro, Ruy ; Lyman, William. / Maternofetal transmission of human immunodeficiency virus-1 : The role of antibodies to the V<inf>3</inf> primary neutralizing domain. In: Pediatric Research. 1993 ; Vol. 33, No. 1. pp. S76-S79.
@article{b87822f636f04d85b02aa634c1c5c1f2,
title = "Maternofetal transmission of human immunodeficiency virus-1: The role of antibodies to the V3 primary neutralizing domain",
abstract = "The increase in the number of human immunodeficiency virus-1 (HIV-1)-infected children is a direct consequence of the heterosexual spread of the disease to women and the growing number of HIV-positive i.v. drug users. It is not known how the majority of infants born to HIV-1-infected women escape HIV-1 infection, and, for those infected, the timing of HIV-1 transmission has yet to be determined. In addition, the role of maternal antibodies in the prevention of HIV-1 transmission to the fetus is unclear. We have previously demonstrated a correlation between vertical transmission and the absence of high-affinity/avidity antibodies to a peptide, KRI-HIGPGRAFYT, which corresponds to a region of the primary neutralizing domain of the gpl20 V3 loop of HIVMN (MN-PND). The present study examines the correlation between the presence of these high affinity antibodies in women completing a pregnancy or undergoing an elective abortion and the detection of HIV-1 infection in their aborted fetuses. In several instances, transmission occurred despite high-affinity antibodies to the MN-PND. We have, therefore, evaluated the reactivity of sera to different MN-PND variants. In one infant born to a mother with high-affinity/avidity antibodies to KRI-HIGPGRAFYT (classic MN-PND), the infected baby developed antibodies to an MN-PND variant peptide against which his mother did not mount a humoral immune response during pregnancy. This finding indicates that fetal infection with MN-PND escape mutants arising during pregnancy may occur during a period when the mother is serologically negative.",
author = "Arye Rubinstein and Harris Goldstein and Theresa Calvelli and Yair Devash and Ran Rubinstein and Ruy Soeiro and William Lyman",
year = "1993",
language = "English (US)",
volume = "33",
pages = "S76--S79",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Maternofetal transmission of human immunodeficiency virus-1

T2 - The role of antibodies to the V3 primary neutralizing domain

AU - Rubinstein, Arye

AU - Goldstein, Harris

AU - Calvelli, Theresa

AU - Devash, Yair

AU - Rubinstein, Ran

AU - Soeiro, Ruy

AU - Lyman, William

PY - 1993

Y1 - 1993

N2 - The increase in the number of human immunodeficiency virus-1 (HIV-1)-infected children is a direct consequence of the heterosexual spread of the disease to women and the growing number of HIV-positive i.v. drug users. It is not known how the majority of infants born to HIV-1-infected women escape HIV-1 infection, and, for those infected, the timing of HIV-1 transmission has yet to be determined. In addition, the role of maternal antibodies in the prevention of HIV-1 transmission to the fetus is unclear. We have previously demonstrated a correlation between vertical transmission and the absence of high-affinity/avidity antibodies to a peptide, KRI-HIGPGRAFYT, which corresponds to a region of the primary neutralizing domain of the gpl20 V3 loop of HIVMN (MN-PND). The present study examines the correlation between the presence of these high affinity antibodies in women completing a pregnancy or undergoing an elective abortion and the detection of HIV-1 infection in their aborted fetuses. In several instances, transmission occurred despite high-affinity antibodies to the MN-PND. We have, therefore, evaluated the reactivity of sera to different MN-PND variants. In one infant born to a mother with high-affinity/avidity antibodies to KRI-HIGPGRAFYT (classic MN-PND), the infected baby developed antibodies to an MN-PND variant peptide against which his mother did not mount a humoral immune response during pregnancy. This finding indicates that fetal infection with MN-PND escape mutants arising during pregnancy may occur during a period when the mother is serologically negative.

AB - The increase in the number of human immunodeficiency virus-1 (HIV-1)-infected children is a direct consequence of the heterosexual spread of the disease to women and the growing number of HIV-positive i.v. drug users. It is not known how the majority of infants born to HIV-1-infected women escape HIV-1 infection, and, for those infected, the timing of HIV-1 transmission has yet to be determined. In addition, the role of maternal antibodies in the prevention of HIV-1 transmission to the fetus is unclear. We have previously demonstrated a correlation between vertical transmission and the absence of high-affinity/avidity antibodies to a peptide, KRI-HIGPGRAFYT, which corresponds to a region of the primary neutralizing domain of the gpl20 V3 loop of HIVMN (MN-PND). The present study examines the correlation between the presence of these high affinity antibodies in women completing a pregnancy or undergoing an elective abortion and the detection of HIV-1 infection in their aborted fetuses. In several instances, transmission occurred despite high-affinity antibodies to the MN-PND. We have, therefore, evaluated the reactivity of sera to different MN-PND variants. In one infant born to a mother with high-affinity/avidity antibodies to KRI-HIGPGRAFYT (classic MN-PND), the infected baby developed antibodies to an MN-PND variant peptide against which his mother did not mount a humoral immune response during pregnancy. This finding indicates that fetal infection with MN-PND escape mutants arising during pregnancy may occur during a period when the mother is serologically negative.

UR - http://www.scopus.com/inward/record.url?scp=0027419865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027419865&partnerID=8YFLogxK

M3 - Article

C2 - 8433879

AN - SCOPUS:0027419865

VL - 33

SP - S76-S79

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 1

ER -